We sit down with you and build your perfect lead list. Book a call with founders.

VedaBio Analysis

What is VedaBio?

VedaBio is a biotechnology company specializing in ultra-rapid molecular detection using its CRISPR Cascade™ platform for accurate results without target amplification.

Employees
30
Founded
2021
Company Stage
Series A
YC Batch
S21

Product Features & Capabilities

  • Ultra-rapid molecular detection, CRISPR Cascade™ platform, target amplification-free detection, massive multiplexing capability, rapid reprogramming for new targets.

Who are the founders of VedaBio

Investors

  • OMX Ventures (lead investor)
  • Other undisclosed investors contributing to the initial funding of over $40 million

Find more companies like VedaBio

in Y Combinator batch S21 companies

Financial Overview

Series A
October 17, 2023
Investors: OMX Ventures, Kleinmuntz Associates
Want to research more data points on VedaBio?
Start with Extruct